U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

The FDA Drug Shortage database is currently experiencing technical difficulties and some of the information contained in the database may not reflect the current supply status.

Start Over | Back to Previous Screen

Remifentanil Injection
Status: Currently in Shortage
»Date first posted: 06/28/2022
»Therapeutic Categories: Analgesia/Addiction

Expand all

Fresenius Kabi USA (Revised 08/12/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg per vial, SDV (NDC 63323-723-03) Backordered. Next release August 2022. Demand increase for the drug
2 mg per vial, SDV (NDC 63323-724-05) Backordered. Next release not available at this time. Demand increase for the drug
5 mg per vial, SDV (NDC 63323-725-10) Backordered. Next release August 2022. Demand increase for the drug

Hikma Pharmaceuticals (New 06/28/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/vial (NDC 0143-9391-10) Currently available Demand increase for the drug
2 mg/Vial (NDC 0143-9392-10) This presentation is on backorder. Demand increase for the drug
5 mg/mL (NDC 0143-9393-10) Currently available Demand increase for the drug

Mylan, a Viatris Company (Reverified 07/19/2022)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg (NDC 67457-198-03) Resupply in August 2022 Demand increase for the drug
2 mg (NDC 67457-198-05) Available Demand increase for the drug
5 mg (NDC 67457-198-10) Available Demand increase for the drug
Back to Top